Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: the LixiLan-L randomized trial
Our physicians provide treatment protocols based on patients conditions, objectives, biology, and lifestyle
Morieri ML, Candido R, Frontoni S, et al
Limitations Zepbound should not be used in patients with a history or family history of thyroid cell tumors (MTC) and endocrine cancers (MEN 2 syndrome)
3- Energy and Recovery Optimization IGF-1 signaling influences mitochondrial biogenesis , improving energy production and endurance capacity
Dont forget to follow us on Facebook and Instagram and check back with us each month as we provide you helpful wellness and health information.